Story perspectives

EU Advocates AI in Rare-Disease Diagnosis for Patient Rights

9/25/2025

Summary

Story summary

September 2025, the European Economic and Social Committee (EESC) adopted AI and Big Data opinion on rare-disease diagnosis.
The opinion prioritizes faster patient pathways, personalized medicine, and ethical safeguards protecting patient rights.
It calls for EU health data digitization, anonymized access, and diverse AI training data.
AMT-130 slows Huntington's disease with FDA approval plans, while ProRNA3D-single advances AI-driven molecular modeling.

1 of 1

Story summary

September 2025, the European Economic and Social Committee (EESC) adopted AI and Big Data opinion on rare-disease diagnosis.
The opinion prioritizes faster patient pathways, personalized medicine, and ethical safeguards protecting patient rights.
It calls for EU health data digitization, anonymized access, and diverse AI training data.
AMT-130 slows Huntington's disease with FDA approval plans, while ProRNA3D-single advances AI-driven molecular modeling.